Research library

1,765 reports · By date added

A-shares remain in a bottoming process after a high-volume rebound; Cailian Press sees technology as key to a medium-term recovery

On 2 November, the index reversed last Friday’s losses on higher volume. AI applications led gains, while technology hardware came under pressure in the afternoon. Cailian Press says the index remains in a downtrend and that technology’s performance is key to a medium-term rebound. It also examines the business dynamics of short-drama platforms, mineral water and Token services.

Embodied AI data collection: Zheshang Securities forecasts midstream market to reach 174.1 billion yuan by 2030

Robot training requires large amounts of data from real-world scenarios, and different collection methods involve trade-offs in quality, cost, and scale. Zheshang Securities forecasts that the midstream data collection market will reach 174.1 billion yuan by 2030; the capital increase and shareholding restructuring of the Hangzhou embodied AI pilot base are expected to be completed by the end of 2026.

Zhongsheng Pharmaceutical: Two metabolic drugs support a valuation reassessment, while profit is expected to fall in 2026

Huachuang Securities is optimistic about the commercial potential of Zhongsheng Pharmaceutical’s weight-loss drug RAY1225 and MASH drug ZSP1601. The two pipeline assets have a combined risk-adjusted net present value attributable to the parent of 26.53 billion yuan; meanwhile, the brokerage expects the company’s net profit attributable to the parent to decline 19.7% year on year in 2026.

As physical AI moves toward generalization, where can opportunities near the bottom be found in metals, functional sugars and building materials?

Sinolink Securities is focusing on robots’ shift from one-off demonstrations to learning from demonstrations and productive output. Changjiang Securities and CSC Financial are respectively looking for opportunities in metals, functional sugars and building materials through supply, costs and profitability at low levels.